Research indicates that strict COVID-19 lockdowns might be responsible for delaying normal cardiorespiratory development in children. The study found that a group of 12-14-year-olds in Spain - who were tested pre-pandemic in November 2019 and then again in November 2020 - displayed lower levels of fitness than would be expected with maximal oxygen intake (VO2 max) development, which increases with age.
What The Study Did: This study looked at the use of consumer digital information for COVID-19 control U.S. adults consider to be acceptable and the factors associated with higher or lower approval of using this information.
What The Study Did: SARS-CoV-2 seropositivity wasn't associated with low levels of vitamin D independently of other risk factors.
What The Study Did: Clinical characteristics and outcomes of patients with multisystem inflammatory syndrome among adults with laboratory-confirmed SARS-CoV-2 infection at a single U.S. medical center are described in this study.
Cancer drugs capable of weakening the body's immune defenses are no more likely to increase the risk of Covid-19 infection or death than breast cancer therapies that do not undermine the immune system, a new study shows. Researchers say the results challenge initial concerns that such treatments, which poison cancer cells, were too dangerous to continue during the pandemic.
Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference. NAVIGATOR (NCT03347279) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial.
What The Study Did: Telemedicine use grew rapidly during the COVID-19 pandemic but there was geographic variation in its use so researchers in this study examined the association of county-level telemedicine use with community factors among people with commercial or Medicare Advantage insurance.
An artificial intelligence program accurately predicts the risk that lung nodules detected on screening CT will become cancerous, according to a new study.
Approximately two-fifths of Medicare beneficiaries with chronic obstructive pulmonary disease (COPD) have limited access to pulmonary rehabilitation services due to their distance from rehab centers, according to research presented at the ATS 2021 International Conference. More than 24 million U.S. adults suffer from COPD, a smoking related disease.